Metabolex, Abbott deal

The companies will develop drugs and nutritional products for diabetics using Metabolex's intracellular Glucose Transport Signal Transduction (GTST)

Read the full 187 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE